ReviewWorld journal of gastroenterology2024

Role of gut-liver axis and glucagon-like peptide-1 receptor agonists in the treatment of metabolic dysfunction-associated fatty liver disease.

Jakub Rochoń et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.